share_log

博济医药(300404.SZ):科技园公司“硫酸氨基葡萄糖氯化钠复盐”获化学原料药上市申请批准通知书

Boji Medical Technology (300404.SZ): The company's "amino acid glucosamine hydrochloride and sodium chloride complex compound" in the science and technology park has obtained the approval notice for the listing application of active pharmaceutical ingredi

Gelonghui Finance ·  Jun 13 06:38

Boji Medical Technology (300404.SZ) announced on June 13 that its wholly-owned subsidiary, Guangzhou Boji Biomedical Technology Park Co., Ltd. (hereinafter referred to as the "Technology Park Company") applied for and obtained the "Approval Notice for the Application of Listing Chemical Raw Materials for Active Pharmaceutical Ingredients" issued by the National Medical Products Administration for the "sulfate glucosamine chloride sodium complex salt". The "sulfate glucosamine chloride sodium complex salt" can be used to produce related dosage form pharmaceuticals and has anti-inflammatory effects.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment